Literature DB >> 6531065

Effects of aging and dementia upon recent visuospatial memory.

C Flicker, R T Bartus, T H Crook, S H Ferris.   

Abstract

In two experiments, a total of 20 young normals, 29 elderly normals, and 76 elderly demented subjects were administered a computerized delayed visuospatial recall task. Subjects were instructed to remember which room of a 25-room house had a light on in the window. A choice reaction time task was interposed during the delay interval (0-120 seconds) between stimulus presentation and recall. The test was designed to be (1) face valid-relevant to the subjects' everyday lives, (2) sensitive and specific to the cognitive decline associated with senile dementia of the Alzheimer's type (SDAT), and (3) comparable to animal memory tests. Immediate recall of the spatial location of a single stimulus was found to be deficient in severely demented subjects only, and all groups exhibited a decline in recall accuracy with increasing delay intervals. This decline in recall accuracy was greatest in severely demented subjects, smaller in less demented subjects, still smaller in aged normals, and smallest in young normals. No significant forgetting of spatial location occurred between 30 and 120 seconds after stimulus presentation. Increasing stimulus number decreased recall accuracy in all groups and the elderly and elderly demented subjects were more sensitive to the increase in stimulus load than the young normals. Choice reaction time also proved sensitive to age and severity of dementia. Correlation analyses demonstrated that delayed spatial recall (as well as choice reaction time) is highly correlated with clinically evaluated global cognitive status, as well as with tests of verbal recall.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1984        PMID: 6531065     DOI: 10.1016/0197-4580(84)90003-4

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  20 in total

Review 1.  Changes in cognition.

Authors:  Marilyn S Albert
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

Review 2.  The neuropsychological profile of Alzheimer disease.

Authors:  Sandra Weintraub; Alissa H Wicklund; David P Salmon
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

3.  Different macaque models of cognitive aging exhibit task-dependent behavioral disparities.

Authors:  Alison E Comrie; Daniel T Gray; Anne C Smith; Carol A Barnes
Journal:  Behav Brain Res       Date:  2018-02-09       Impact factor: 3.332

4.  Comparison of the effects of four cholinomimetic agents on cognition in primates following disruption by scopolamine or by lists of objects.

Authors:  N M Rupniak; M J Steventon; M J Field; C A Jennings; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 5.  Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease.

Authors:  M P McDonald; J N Crawley
Journal:  J Psychiatry Neurosci       Date:  1997-11       Impact factor: 6.186

6.  Hypersensitivity to scopolamine in the elderly.

Authors:  C Flicker; S H Ferris; M Serby
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Assessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human aging.

Authors:  Joseph A Araujo; Christa M Studzinski; Elizabeth Head; Carl W Cotman; Norton W Milgram
Journal:  Age (Dordr)       Date:  2005-05-02

8.  Functional and neurobiological similarities of aging in monkeys and humans.

Authors:  M L Voytko
Journal:  Age (Omaha)       Date:  1997-01

9.  Delay-dependent short-term memory deficits in aged rats.

Authors:  S B Dunnett; J L Evenden; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Ondansetron improves cognitive performance in the Morris water maze spatial navigation task.

Authors:  D J Fontana; S E Daniels; C Henderson; R M Eglen; E H Wong
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.